Abstract:The circadian clocks communicating tumour immune microenvironment (TIME) and the immunogenicity of colorectal cancer (CRC) cells. The TIME and immunogenicity of CRC cells are time‐dependent. TIME: the circadian clocks regulate the infiltration and function of Th 17, Treg cells, CD8 + T cells and tumour associated macrophages (TAMs). Tumour‐associated fibroblasts (CAFs) affect the recruitment of immune cells in TIME by secretion of growth factors, cytokines and chemokines, serving as its role in molecular circadian clockwork. The immunogenicity of CRC cell: the circadian clocks influence the microsatellite instability (MSI) status, tumour mutation burden (TMB) and the expression of PD‐L1 of CRC cells, thus changing the immunogenicity of CRC cells. Therefore, circadian clocks could influence responses to anti‐programmed death‐1 therapy by regulating the two important sides. The clock‐targeting drugs (RORα agonist and RORγ agonist) could enhance the efficacy of immune checkpoint inhibitor therapy by regulating the TIME. (Arrows represent positive or upregulated relationships; flat connectors represent negative or inhibitory relationships. TIME means both tumour immune microenvironment and time.) Colorectal cancer (CRC) is one of the most common malignant tumours and the third most common cause of cancer deaths worldwide, with high morbidity and mortality. Circadian clocks are widespread in humans and temporally regulate physiologic functions to maintain homeostasis. Recent studies showed that circadian components were strong regulators of the tumour immune microenvironment (TIME) and the immunogenicity of CRC cells. Therefore, insight into immunotherapy from the perspective of circadian clocks can be promising. Although immunotherapy, especially immune checkpoint inhibitor (ICI) treatment, has been a milestone in cancer treatment, greater accuracy is still needed for selecting patients who will respond positively to immunotherapy with minimal side effects. In addition, there were few reviews focusing on the role of the circadian components in the TIME and the immunogenicity of CRC cells. Therefore, this review highlights the crosstalk between the TIME in CRC and the immunogenicity of CRC cells based on the circadian clocks. With the goal to achieve the possibility that patients with CRC can benefit most from the ICI treatment, we provide potential evidence and a novel idea for building a predictive framework combined with circadian factors, searching for enhancers of ICIs targeting circadian components and clinically implementing the timing of ICI treatment for patients with CRC.

Identification of potential circadian genes and associated pathways in colorectal cancer progression and prognosis using microarray gene expression analysis

Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning

The Role of Circadian Rhythm in the Pathogenesis of Colorectal Cancer

The Role of Circadian Clock Genes in Colorectal Carcinoma: Novel Insights into Regulatory Mechanism and Implications in Clinical Therapy.

Dysregulation of Circadian Clock Genes Associated with Tumor Immunity and Prognosis in Patients with Colon Cancer

Circadian Clock Pathway Genes Associated with Colorectal Cancer Risk and Prognosis

Circadian Regulator-Mediated Molecular Subtypes Depict the Features of Tumor Microenvironment and Indicate Prognosis in Head and Neck Squamous Cell Carcinoma

Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity

The circadian clock circuitry deconvolutes colorectal cancer and lung adenocarcinoma heterogeneity in a dynamic time-related framework

Circadian Gene Hclock Contributes To Progression Of Colorectal Carcinoma And Is Directly Regulated By Tumor-Suppressive Microrna-124

Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer

Circadian Gene Hclock Enhances Proliferation and Inhibits Apoptosis of Human Colorectal Carcinoma Cells in Vitro and in Vivo

Expression profile and prognostic value of the circadian clock in clear cell renal cell carcinoma

Upregulation of Circadian Gene 'hclock' Contribution to Metastasis of Colorectal Cancer

Exploring transcriptomic databases: unraveling circadian gene disruptions in lower grade glioma

Circadian rhythm-associated clinical relevance and Tumor Microenvironment of Non-small Cell Lung Cancer

Integrated bioinformatics approach to unwind key genes and pathways involved in colorectal cancer

Insight into immune checkpoint inhibitor therapy for colorectal cancer from the perspective of circadian clocks

Identify and validate circadian regulators as potential prognostic markers and immune infiltrates in head and neck squamous cell carcinoma

A signature based on circadian rhythm-associated genes for the evaluation of prognosis and the tumour microenvironment in HNSCC

Multi-omics and single-cell sequencing analyses reveal the potential significance of circadian pathways in cancer therapy